Jump Financial’s Astrana Health ASTH Stock Holding History

Jump Financial’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,486	Closed	-$310K	–	2492
2025 Q4	$310K	Buy	+12,486	New	+$332K	﹤0.01%	1541
2022 Q2	–	Sell	-9,800	Closed	-$475K	–	2085
2022 Q1	$475K	Buy	+9,800	New	+$506K	0.02%	837

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Jump Financial's ASTH Position: Q1 2026 in Review

Jump Financial sold out of Astrana Health (ASTH) in Q1 2026, closing a stake of 12,486 shares — an estimated $310K sold.

Jump Financial first reported a position in ASTH in Q1 2022 and held it in 2 quarters. The position peaked at $475K in Q1 2022. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

Jump Financial reported no remaining Astrana Health position as of Q1 2026 after selling out during the quarter.
Jump Financial sold 12,486 Astrana Health shares in Q1 2026, an estimated $310K.
Jump Financial first reported a position in Astrana Health in Q1 2022 and held it in 2 quarters.
Jump Financial's Astrana Health position peaked at $475K in Q1 2022.
171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.